Composition
- Active ingredients
- EFAVIRENZ 600MG; EMTRICITABINE 200MG; TENOFOVIR DISOPROXIL FUMARATE 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021937.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Atripla
- Active substance
- efavirenz
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Gilead Sciences
- Status
- Discontinued
- FDA approval
- 12 Jul 2006
- Application
- NDA021937-001